Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.05 - $12.02 $502,500 - $601,000
-50,000 Reduced 20.0%
200,000 $2.13 Million
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $2.82 Million - $3.38 Million
250,000 New
250,000 $2.99 Million
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $4 Million - $5.34 Million
-435,300 Reduced 88.6%
56,000 $539,000
Q4 2022

Feb 14, 2023

BUY
$8.72 - $11.56 $3.22 Million - $4.26 Million
368,800 Added 301.06%
491,300 $5.47 Million
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $14,416 - $18,921
-1,700 Reduced 1.37%
122,500 $1.04 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.